Skip to content
  • (+61) 2 8203 8741
  • [email protected]
Search
Close
FreshleafAnalytics-logo
  • About Us
    • Our team
  • Services
    • Freshleaf Reports
  • Partners
  • Media
  • News
  • Contact us
Menu
  • About Us
    • Our team
  • Services
    • Freshleaf Reports
  • Partners
  • Media
  • News
  • Contact us
Report H2 2021
Read more about the article Approvals for medicinal cannabis prescriptions hit “record high”

Approvals for medicinal cannabis prescriptions hit “record high”

  • Post author:FreshLeaf Analytics
  • Post published:September 9, 2021
  • Post category:Media
  • Post comments:0 Comments

Ten years ago Collaroy resident Ashlee developed chronic neuropathic pain after a car accident left her with broken ribs.

Continue ReadingApprovals for medicinal cannabis prescriptions hit “record high”
FreshleafAnalytics-logo

The team at FreshLeaf Analytics are experts in the medicinal cannabis market in Australia. 

Contact us

  • [email protected]
  • (+61) 2 8203 8741
  • Follow us!
Facebook-f Twitter Linkedin

Get in touch!

© 2022 All rights reserved​, FreshLeaf Analytics

FreshLeaf Analytics H2 2021

The H2 2021 report is FreshLeaf Analytics’ seventh market
report on patients, products and pricing in the Australian
medicinal cannabis market.

Key highlights include:

  • Market growth will exceed expectations in 2021 as active patient numbers surge towards 100,000
  • Revenue from product sales forecast at $230 million at year end
  • Product count continues to climb although the growth rate of new products is slowing
  • Average monthly spend continues its slow downward trend while average daily dose increases
Download Report H2 2021